Building 8
No. 8 Life Science Park Road Zhongguancun Life Science Park Changping District
Beijing 102206
China
86 10 6660 9999
https://www.innocarepharma.com
版塊: Healthcare
行業: Biotechnology
全職員工: 1,089
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Jisong Cui Ph.D. | Co-Founder, Chairwoman & CEO | 8.23M | 無 | 1964 |
Dr. Renbin Zhao Ph.D. | VP of Regulatory Affairs & Clinical Development and Executive Director | 3.19M | 無 | 1969 |
Mr. Xin Fu | Chief Financial Officer | 無 | 無 | 無 |
Mr. Nan Gao | Chief Operating Officer | 無 | 無 | 1974 |
Dr. Xiangyang Chen Ph.D. | Chief Technology Officer | 無 | 無 | 1968 |
Ms. Junsu Wang | General Counsel | 無 | 無 | 1977 |
Dr. Xiang-Yang Zhang M.D. | Chief Medical Officer | 無 | 無 | 1963 |
Mr. Davy Ouyang Ph.D. | VP & Head of Biology | 無 | 無 | 無 |
Mr. Jeff Chen | Chief Commercial Officer | 無 | 無 | 無 |
Ms. Pui Shan Lee | Company Secretary | 無 | 無 | 無 |
集團是一家處於臨床階段的生物醫藥公司,致力於開發及商業化用於治療癌症及自身免疫性疾病的潛在同類最佳及/或首創的分子靶向藥物。
截至 無 止,諾誠健華 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。